Abstract. Seven patients with minimal-change nephrotic syndrome confirmed by renal biopsy were treated with cyclosporin (CsA). Four patients had frequent relapses and three others had primary steroid resistant nephrotic syndrome. Corticosteroids were discontinued as soon as CsA whole blood trough values of 200-500 ng/ml (RIA method) were reached. A full remission, defined as com-plete disappearance of proteinuria, was achieved in five patients under this treatment. In the two other patients proteinuria was reduced. Two patients experienced an acute episode of dose-dependent nephrotoxicity; however, overall renal func-tion, as determined by the creatinine clearance, was stable. Control biopsies in five patients after a mean treat-ment period...
This study was conducted to evaluate the safety and ef-ficacy of tacrolimus (TAC) in children with S...
Background. Chronic kidney disease (CKD) is a compli-cation of heart transplantation related to calc...
Contains fulltext : 174168.pdf (publisher's version ) (Closed access)BACKGROUND: F...
Background Cyclosporine and prednisolone combination therapy has been used in the treatment of minim...
Background. Renal outcome after ciclosporin (CsA) is not clear in most studies involving patients wi...
Background. Cyclosporine A (CyA) has been shown to be effective in membranous nephropathy (MN). Howe...
Abstract. To test the effects of short-term therapy with low doses (LD) of cyclosporin A (CsA) in su...
Background. Severe steroid-dependent nephrotic syndrome (SDNS) is a common type of nephrotic syndrom...
Background. Severe steroid-dependent nephrotic syndrome (SDNS) is a common type of nephrotic syndrom...
Background. The deliberate use of ketoconazole to reduce the need for cyclosporine (CsA) is not new,...
Background. Non-IgA mesangioproliferative glomerulo-nephritis is a well recognized but less studied ...
slowed the progression of renal dysfunction andDenmark Full list of author information is available ...
Abstract. We retrospectively studied 82 consecutive patients with idiopathic membranous nephropathy ...
Cyclosporine (CyA), a potent immunosup-pressant, has a nephrotoxic side effect. Decrease of glomerul...
<em>The article analyzes results of successful prolonged treatment of children with focal segmental ...
This study was conducted to evaluate the safety and ef-ficacy of tacrolimus (TAC) in children with S...
Background. Chronic kidney disease (CKD) is a compli-cation of heart transplantation related to calc...
Contains fulltext : 174168.pdf (publisher's version ) (Closed access)BACKGROUND: F...
Background Cyclosporine and prednisolone combination therapy has been used in the treatment of minim...
Background. Renal outcome after ciclosporin (CsA) is not clear in most studies involving patients wi...
Background. Cyclosporine A (CyA) has been shown to be effective in membranous nephropathy (MN). Howe...
Abstract. To test the effects of short-term therapy with low doses (LD) of cyclosporin A (CsA) in su...
Background. Severe steroid-dependent nephrotic syndrome (SDNS) is a common type of nephrotic syndrom...
Background. Severe steroid-dependent nephrotic syndrome (SDNS) is a common type of nephrotic syndrom...
Background. The deliberate use of ketoconazole to reduce the need for cyclosporine (CsA) is not new,...
Background. Non-IgA mesangioproliferative glomerulo-nephritis is a well recognized but less studied ...
slowed the progression of renal dysfunction andDenmark Full list of author information is available ...
Abstract. We retrospectively studied 82 consecutive patients with idiopathic membranous nephropathy ...
Cyclosporine (CyA), a potent immunosup-pressant, has a nephrotoxic side effect. Decrease of glomerul...
<em>The article analyzes results of successful prolonged treatment of children with focal segmental ...
This study was conducted to evaluate the safety and ef-ficacy of tacrolimus (TAC) in children with S...
Background. Chronic kidney disease (CKD) is a compli-cation of heart transplantation related to calc...
Contains fulltext : 174168.pdf (publisher's version ) (Closed access)BACKGROUND: F...